Tora S.
- Country
- Norway
- Department
- Department of cancer research and molecular medicine
Research Overview
- Evaluation of 177Lu-PSMA Theranostics in Recurrent Grade 3 and Grade 4 Glioma: Safety, Tolerability, and Efficacy Analysis
- Phase 1/2 Evaluation of Synthetic Cannabinoid ART27.13 for Cancer Anorexia and Weight Loss in Oncology Patients
- Phase IB/II Study of Bortezomib and Temozolomide in Recurrent Grade IV Glioma with Unmethylated MGMT Promoter
Data & Insights
Has run more than one trial at 2 of 53 partner sites.
Specializations
Neuro-Oncology Focus
This investigator specializes in the treatment of high-grade gliomas, with particular emphasis on glioblastoma and grade 3 and 4 gliomas. Their research encompasses innovative therapeutic approaches for both newly diagnosed and recurrent cases.
- High-grade brain tumors
- Recurrent glioblastoma management
- Advanced brain tumor therapeutics
Radiotherapy Applications
The investigator explores various radiation therapy approaches, including re-irradiation strategies and their combination with chemotherapy. Their work includes the evaluation of novel radioligand treatments for brain tumors.
- Targeted radiation therapies
- Re-irradiation protocols
- Radioligand therapeutic applications
Advanced Treatment Modalities
Their expertise extends to theranostic approaches in brain tumor treatment, including the application of novel therapeutic compounds and tumor treating fields. The investigator also focuses on meningioma treatment using innovative therapeutic agents.
- Combination therapy strategies
- Theranostic applications
- Novel therapeutic approaches
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.